230 related articles for article (PubMed ID: 19095376)
1. Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment.
Schwartz DL; Lobo MJ; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Evans DB; Clayman G; Sherman SI; Garden AS
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1083-91. PubMed ID: 19095376
[TBL] [Abstract][Full Text] [Related]
2. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
3. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience.
Terezakis SA; Lee KS; Ghossein RA; Rivera M; Tuttle RM; Wolden SL; Zelefsky MJ; Wong RJ; Patel SG; Pfister DG; Shaha AR; Lee NY
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):795-801. PubMed ID: 18676097
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
[TBL] [Abstract][Full Text] [Related]
5. Survival of differentiated thyroid carcinoma studied in 500 patients.
Lerch H; Schober O; Kuwert T; Saur HB
J Clin Oncol; 1997 May; 15(5):2067-75. PubMed ID: 9164219
[TBL] [Abstract][Full Text] [Related]
6. Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era.
Schwartz DL; Rana V; Shaw S; Yazbeck C; Ang KK; Morrison WH; Rosenthal DI; Hoff A; Evans DB; Clayman GL; Garden AS; Sherman SI
Head Neck; 2008 Jul; 30(7):883-8. PubMed ID: 18213725
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
Yang Z; Flores J; Katz S; Nathan CA; Mehta V
Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
[TBL] [Abstract][Full Text] [Related]
8. [Postoperative external beam radiotherapy for medullary thyroid carcinoma with high risk of locoregional relapse].
Compagnon F; Zerdoud S; Rives M; Laprie A; Sarini J; Grunenwald S; Chaltiel L; Graff P
Cancer Radiother; 2016 Jul; 20(5):362-9. PubMed ID: 27396902
[TBL] [Abstract][Full Text] [Related]
9. Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital.
O'Connell ME; A'Hern RP; Harmer CL
Eur J Cancer; 1994; 30A(6):733-9. PubMed ID: 7917529
[TBL] [Abstract][Full Text] [Related]
10. Results of external beam radiotherapy in patients with well differentiated thyroid carcinoma.
Lin JD; Tsang NM; Huang MJ; Weng HF
Jpn J Clin Oncol; 1997 Aug; 27(4):244-7. PubMed ID: 9379512
[TBL] [Abstract][Full Text] [Related]
11. Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS).
Schuck A; Biermann M; Pixberg MK; Müller SB; Heinecke A; Schober O; Willich N
Strahlenther Onkol; 2003 Dec; 179(12):832-9. PubMed ID: 14652672
[TBL] [Abstract][Full Text] [Related]
12. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
[TBL] [Abstract][Full Text] [Related]
13. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
14. The role of postoperative external-beam radiotherapy in the management of patients with papillary thyroid cancer invading the trachea.
Keum KC; Suh YG; Koom WS; Cho JH; Shim SJ; Lee CG; Park CS; Chung WY; Kim GE
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):474-80. PubMed ID: 16542796
[TBL] [Abstract][Full Text] [Related]
15. Differentiated thyroid cancer: prognostic factors and influence of treatment on the outcome in 441 patients.
Sautter-Bihl ML; Raub J; Hetzel-Sesterheim M; Heinze HG
Strahlenther Onkol; 2001 Mar; 177(3):125-31. PubMed ID: 11285769
[TBL] [Abstract][Full Text] [Related]
16. Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases.
Lin JD; Liou MJ; Chao TC; Weng HF; Ho YS
Endocr Relat Cancer; 1999 Mar; 6(1):109-15. PubMed ID: 10732793
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy in well-differentiated thyroid cancer: is it underutilized?
So K; Smith RE; Davis SR
ANZ J Surg; 2016 Sep; 86(9):696-700. PubMed ID: 26573999
[TBL] [Abstract][Full Text] [Related]
18. Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.
Taylor T; Specker B; Robbins J; Sperling M; Ho M; Ain K; Bigos ST; Brierley J; Cooper D; Haugen B; Hay I; Hertzberg V; Klein I; Klein H; Ladenson P; Nishiyama R; Ross D; Sherman S; Maxon HR
Ann Intern Med; 1998 Oct; 129(8):622-7. PubMed ID: 9786809
[TBL] [Abstract][Full Text] [Related]
19. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
20. Does radiation dose matter in thyroid cancer?: Patterns of local-regional failure in recurrent and metastatic well-differentiated thyroid cancers treated with dose-painted intensity-modulated radiation therapy.
Shugard E; Chen J; Quivey JM; Glastonbury CM; Khanafshar E; Garsa AA; George JR; Yom SS
J Med Imaging Radiat Oncol; 2016 Aug; 60(4):560-7. PubMed ID: 27020481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
